Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Emotional Stabilization in BPD
NCT02728778Phase 2Completed
- Sponsor
- Hannover Medical School
- Start
- Sep 2016
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in borderline personality disorder (BPD), sponsored by Hannover Medical School. Started Sep 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT02728778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02728778.